Biopharmaceutical leader in the development of treatments for rare diseases
Federal legislative efforts to enhance the security and integrity of the domestic pharmaceutical distribution system.

Education about the Pre-Existing Condition Insurance Plan (PCIP) in the Affordable Care Act and legislative efforts to redirect funding from other sources into the program. Monitoring the implementation of the Korea-U.S. Free Trade Agreement, as it relates to transparency in Korean government coverage and reimbursement of biologics. H.R. 8: American Taxpayer Relief Act of 2012 as it relates to sequestration and Medicare, including updates to the Medicare Sustainable Growth rate formula for physicians and related issues.
HCR - Health Issues TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX